Spatially Resolved Epithelial–Immune Heterogeneity Identifies an Endometriosis Subtype with Molecular Features of Endometriosis-Associated Ovarian Cancer

In: Research Square · 2026 · doi:10.21203/rs.3.rs-10497180/v1 · W7204129191
preprint OA: green CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-08-28 ⓘ

Spatial transcriptomics of endometriosis and ovarian cancer reveals a "cancer-like" endometriosis subtype characterized by oncogenic signaling, specific gene expression, and an immunosuppressive microenvironment distinct from typical lesions.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-27 · read from full text ⓘ

This preprint utilizes spatial transcriptomics to map epithelial and immune cell interactions in tissue samples from patients with simple endometriosis, atypical endometriosis, PD-L1-positive cancer-like endometriosis, and endometriosis-associated ovarian cancers. The study reveals that cancer-like endometriosis lesions exhibit significant enrichment in oncogenic signaling, extracellular matrix remodeling, and a distinct immune microenvironment characterized by M2-macrophage dominance and T-cell depletion, despite appearing conventional histologically. These findings support a model where endometriosis contributes to tumorigenesis through either an inflammatory damage-repair loop or hormone-driven proliferative signaling, offering a spatial framework for risk stratification. This paper is centrally about endometriosis — specifically identifying a molecular subtype with features of endometriosis-associated ovarian cancer.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Evidence suggests that clear cell and endometrioid ovarian carcinoma may arise from endometriosis. We previously identified that some endometriosis lesions exhibit a “cancer-like” PD-1/PD-L1 positive staining similar to endometriosis-associated ovarian cancers. If this condition is associated with oncogenic signaling and immune tolerance is currently unknown. Using spatial transcriptomics, we mapped epithelial cells, T lymphocytes and macrophages in 14 patients including simple endometriosis (n = 2), atypical endometriosis (n = 2), PD-L1-positive “cancer-like” endometriosis (n = 4), endometriosis-associated clear cell (n = 3) and endometrioid ovarian carcinoma (n = 3). We found that epithelial cells in cancer-like endometriosis, despite a conventional histological appearance, display significant enrichment in oncogenic signaling, extracellular matrix remodeling and wound-healing programs. This phenotype is further defined by epithelial NNMT and MUC5B expression, subepithelial neutrophil infiltration, and a shift toward an M2-macrophage-dominant, T-CD8 + cell depleted microenvironment. Proliferative signaling was enriched in endometroid carcinoma and adjacent endometriotic epithelium, while secretory signaling in cancer-like endometriosis, clear cell carcinoma and adjacent endometriotic areas. Our findings support a model of endometriosis-associated tumorigenesis through two different mechanisms: a damage-repair/inflammatory loop mimicking a “window-of-implantation-like” secretory niche or a hormone-driven proliferative signaling, providing a spatial framework for risk stratification.
Full text 19,764 characters · extracted from preprint-html · click to expand
Spatially Resolved Epithelial–Immune Heterogeneity Identifies an Endometriosis Subtype with Molecular Features of Endometriosis-Associated Ovarian Cancer | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Help Center Sign In Submit a Preprint Cite Share Download PDF Article Spatially Resolved Epithelial–Immune Heterogeneity Identifies an Endometriosis Subtype with Molecular Features of Endometriosis-Associated Ovarian Cancer Valentina Iacobelli, Luca Mastrantoni, Stefano Alivernini, Giulia Scaglione, and 13 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-10497180/v1 This work is licensed under a CC BY 4.0 License Status: Under Review Version 1 posted 9 You are reading this latest preprint version Abstract Evidence suggests that clear cell and endometrioid ovarian carcinoma may arise from endometriosis. We previously identified that some endometriosis lesions exhibit a “cancer-like” PD-1/PD-L1 positive staining similar to endometriosis-associated ovarian cancers. If this condition is associated with oncogenic signaling and immune tolerance is currently unknown. Using spatial transcriptomics, we mapped epithelial cells, T lymphocytes and macrophages in 14 patients including simple endometriosis (n = 2), atypical endometriosis (n = 2), PD-L1-positive “cancer-like” endometriosis (n = 4), endometriosis-associated clear cell (n = 3) and endometrioid ovarian carcinoma (n = 3). We found that epithelial cells in cancer-like endometriosis, despite a conventional histological appearance, display significant enrichment in oncogenic signaling, extracellular matrix remodeling and wound-healing programs. This phenotype is further defined by epithelial NNMT and MUC5B expression, subepithelial neutrophil infiltration, and a shift toward an M2-macrophage-dominant, T-CD8 + cell depleted microenvironment. Proliferative signaling was enriched in endometroid carcinoma and adjacent endometriotic epithelium, while secretory signaling in cancer-like endometriosis, clear cell carcinoma and adjacent endometriotic areas. Our findings support a model of endometriosis-associated tumorigenesis through two different mechanisms: a damage-repair/inflammatory loop mimicking a “window-of-implantation-like” secretory niche or a hormone-driven proliferative signaling, providing a spatial framework for risk stratification. Biological sciences/Cancer Biological sciences/Cell biology Health sciences/Diseases Health sciences/Oncology Full Text Additional Declarations No competing interests reported. Supplementary Files SupplementaryMaterial.docx Cite Share Download PDF Status: Under Review Version 1 posted Reviews received at journal 26 Aug, 2026 Reviews received at journal 24 Aug, 2026 Reviewers agreed at journal 19 Aug, 2026 Reviewers agreed at journal 18 Aug, 2026 Reviewers agreed at journal 16 Aug, 2026 Reviewers invited by journal 15 Aug, 2026 Editor assigned by journal 09 Aug, 2026 Submission checks completed at journal 29 Jul, 2026 First submitted to journal 27 Jul, 2026 You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-10497180","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":700452468,"identity":"ee080a78-f46a-404d-a50f-da29e244293a","order_by":0,"name":"Valentina Iacobelli","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Valentina","middleName":"","lastName":"Iacobelli","suffix":""},{"id":700452469,"identity":"0e84a2a0-5415-4267-8514-409d624264fc","order_by":1,"name":"Luca Mastrantoni","email":"","orcid":"","institution":"Catholic University of the Sacred Heart","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Luca","middleName":"","lastName":"Mastrantoni","suffix":""},{"id":700452470,"identity":"67eee2aa-cc73-4f79-a17d-90152791867e","order_by":2,"name":"Stefano Alivernini","email":"","orcid":"","institution":"Catholic University of the Sacred Heart","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Stefano","middleName":"","lastName":"Alivernini","suffix":""},{"id":700452471,"identity":"30b5d68c-33fc-4180-9119-fa4cb3f15151","order_by":3,"name":"Giulia Scaglione","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Giulia","middleName":"","lastName":"Scaglione","suffix":""},{"id":700452472,"identity":"1beb3b3c-79f4-4c7f-addc-d11f87b5e610","order_by":4,"name":"Antonio Agostini","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Antonio","middleName":"","lastName":"Agostini","suffix":""},{"id":700452473,"identity":"75d75045-6296-4956-ae39-2fa69921ddd0","order_by":5,"name":"Giulia Mantini","email":"","orcid":"","institution":"Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Giulia","middleName":"","lastName":"Mantini","suffix":""},{"id":700452474,"identity":"987db178-77e4-43b8-8b28-dd7be3ea55b3","order_by":6,"name":"Alessia Piermattei","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Alessia","middleName":"","lastName":"Piermattei","suffix":""},{"id":700452475,"identity":"82229770-0002-4a9c-8fd1-40d7162d0ca8","order_by":7,"name":"Federica Persiani","email":"","orcid":"","institution":"Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Federica","middleName":"","lastName":"Persiani","suffix":""},{"id":700452476,"identity":"c570b340-8cae-474c-82c3-e58919e72389","order_by":8,"name":"Floriana Camarda","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Floriana","middleName":"","lastName":"Camarda","suffix":""},{"id":700452477,"identity":"4880f27c-96b2-4353-a35a-0eb0f6ef45d6","order_by":9,"name":"Rita Trozzi","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Rita","middleName":"","lastName":"Trozzi","suffix":""},{"id":700452478,"identity":"0ca8b4b6-4c98-4a46-9f12-0e6c8c85ef25","order_by":10,"name":"Francesca Sillano","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Francesca","middleName":"","lastName":"Sillano","suffix":""},{"id":700452479,"identity":"9a439733-46f2-4940-a6c9-b72f0e416c0f","order_by":11,"name":"Maria Antonietta D’Agostino","email":"","orcid":"","institution":"Catholic University of the Sacred Heart","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Maria","middleName":"Antonietta","lastName":"D’Agostino","suffix":""},{"id":700452480,"identity":"eb2d683c-dca4-4fbd-8789-5b81f6156cc2","order_by":12,"name":"Georg Schett","email":"","orcid":"","institution":"Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Georg","middleName":"","lastName":"Schett","suffix":""},{"id":700452481,"identity":"b253d964-e7c0-4a82-8b08-599e70774ec9","order_by":13,"name":"Carmine Carbone","email":"","orcid":"","institution":"Fondazione Policlinico Universitario Agostino Gemelli, IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Carmine","middleName":"","lastName":"Carbone","suffix":""},{"id":700452482,"identity":"899faa22-3f15-435b-b1be-9cee1aec97ac","order_by":14,"name":"Giovanni Scambia","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Giovanni","middleName":"","lastName":"Scambia","suffix":""},{"id":700452483,"identity":"db6193b9-e2f0-48be-af1d-5a96b3b2e8cf","order_by":15,"name":"Anna Fagotti","email":"","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":false,"submittingAuthor":false,"prefix":"","firstName":"Anna","middleName":"","lastName":"Fagotti","suffix":""},{"id":700452484,"identity":"fb5d9ce8-d607-47f3-bc4b-5f543f658731","order_by":16,"name":"Camilla Nero","email":"data:image/png;base64,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","orcid":"","institution":"Fondazione Policlinico Universitario A. Gemelli IRCCS","correspondingAuthor":true,"submittingAuthor":false,"prefix":"","firstName":"Camilla","middleName":"","lastName":"Nero","suffix":""}],"badges":[],"createdAt":"2026-07-27 10:40:07","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-10497180/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-10497180/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":118218060,"identity":"4b2b5b32-6f17-4908-a531-130948afd67f","added_by":"auto","created_at":"2026-08-25 07:34:04","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":7328883,"visible":true,"origin":"","legend":"","description":"","filename":"Manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-10497180/v1_covered_ab420caa-2420-48c2-8a42-a92fa9907c9f.pdf"},{"id":118213939,"identity":"5ebea30e-7093-43df-ae63-5903d105101f","added_by":"auto","created_at":"2026-08-25 06:05:44","extension":"docx","order_by":0,"title":"","display":"","copyAsset":false,"role":"supplement","size":4741433,"visible":true,"origin":"","legend":"","description":"","filename":"SupplementaryMaterial.docx","url":"https://assets-eu.researchsquare.com/files/rs-10497180/v1/57f682d00c72e7ec387ca770.docx"}],"financialInterests":"No competing interests reported.","formattedTitle":"Spatially Resolved Epithelial–Immune Heterogeneity Identifies an Endometriosis Subtype with Molecular Features of Endometriosis-Associated Ovarian Cancer","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"npj-precision-oncology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"npjprecisiononcology","sideBox":"Learn more about [npj Precision Oncology](http://www.nature.com/npjprecisiononcology/)","snPcode":"41698","submissionUrl":"https://submission.springernature.com/new-submission/41698/3","title":"npj Precision Oncology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"NPJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-10497180/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-10497180/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eEvidence suggests that clear cell and endometrioid ovarian carcinoma may arise from endometriosis. We previously identified that some endometriosis lesions exhibit a \u0026ldquo;cancer-like\u0026rdquo; PD-1/PD-L1 positive staining similar to endometriosis-associated ovarian cancers. If this condition is associated with oncogenic signaling and immune tolerance is currently unknown.\u003c/p\u003e \u003cp\u003eUsing spatial transcriptomics, we mapped epithelial cells, T lymphocytes and macrophages in 14 patients including simple endometriosis (n\u0026thinsp;=\u0026thinsp;2), atypical endometriosis (n\u0026thinsp;=\u0026thinsp;2), PD-L1-positive \u0026ldquo;cancer-like\u0026rdquo; endometriosis (n\u0026thinsp;=\u0026thinsp;4), endometriosis-associated clear cell (n\u0026thinsp;=\u0026thinsp;3) and endometrioid ovarian carcinoma (n\u0026thinsp;=\u0026thinsp;3). We found that epithelial cells in cancer-like endometriosis, despite a conventional histological appearance, display significant enrichment in oncogenic signaling, extracellular matrix remodeling and wound-healing programs. This phenotype is further defined by epithelial \u003cem\u003eNNMT\u003c/em\u003e and \u003cem\u003eMUC5B\u003c/em\u003e expression, subepithelial neutrophil infiltration, and a shift toward an M2-macrophage-dominant, T-CD8\u0026thinsp;+\u0026thinsp;cell depleted microenvironment.\u003c/p\u003e \u003cp\u003eProliferative signaling was enriched in endometroid carcinoma and adjacent endometriotic epithelium, while secretory signaling in cancer-like endometriosis, clear cell carcinoma and adjacent endometriotic areas.\u003c/p\u003e \u003cp\u003eOur findings support a model of endometriosis-associated tumorigenesis through two different mechanisms: a damage-repair/inflammatory loop mimicking a \u0026ldquo;window-of-implantation-like\u0026rdquo; secretory niche or a hormone-driven proliferative signaling, providing a spatial framework for risk stratification.\u003c/p\u003e","manuscriptTitle":"Spatially Resolved Epithelial–Immune Heterogeneity Identifies an Endometriosis Subtype with Molecular Features of Endometriosis-Associated Ovarian Cancer","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2026-08-25 00:55:10","doi":"10.21203/rs.3.rs-10497180/v1","editorialEvents":[{"type":"communityComments","content":0},{"type":"editorInvitedReview","content":"","date":"2026-08-26T08:10:12+00:00","index":"hide","fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-08-24T10:25:24+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"187626399193702419474010517992736822973","date":"2026-08-19T05:22:53+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"24040887931247321056772173954598410496","date":"2026-08-18T06:48:09+00:00","index":"hide","fulltext":""},{"type":"reviewerAgreed","content":"297671070129276515533240624440701549918","date":"2026-08-16T18:36:53+00:00","index":"hide","fulltext":""},{"type":"reviewersInvited","content":"","date":"2026-08-15T19:52:05+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2026-08-09T21:30:20+00:00","index":"","fulltext":""},{"type":"checksComplete","content":"","date":"2026-07-29T12:08:44+00:00","index":"","fulltext":""},{"type":"submitted","content":"npj Precision Oncology","date":"2026-07-27T10:26:26+00:00","index":"","fulltext":""}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"npj-precision-oncology","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":false,"externalIdentity":"npjprecisiononcology","sideBox":"Learn more about [npj Precision Oncology](http://www.nature.com/npjprecisiononcology/)","snPcode":"41698","submissionUrl":"https://submission.springernature.com/new-submission/41698/3","title":"npj Precision Oncology","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"stoa","reportingPortfolio":"NPJ","inReviewEnabled":true,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"ba7e07d4-9de9-436d-bbaf-84aeb4759b7e","owner":[],"postedDate":"August 25th, 2026","published":true,"recentEditorialEvents":[{"type":"editorInvitedReview","content":"","date":"2026-08-26T08:10:12+00:00","index":16,"fulltext":""},{"type":"editorInvitedReview","content":"","date":"2026-08-24T10:25:24+00:00","index":15,"fulltext":""},{"type":"reviewerAgreed","content":"187626399193702419474010517992736822973","date":"2026-08-19T05:22:53+00:00","index":14,"fulltext":""},{"type":"reviewerAgreed","content":"24040887931247321056772173954598410496","date":"2026-08-18T06:48:09+00:00","index":13,"fulltext":""},{"type":"reviewerAgreed","content":"297671070129276515533240624440701549918","date":"2026-08-16T18:36:53+00:00","index":12,"fulltext":""},{"type":"reviewersInvited","content":"7","date":"2026-08-15T19:52:05+00:00","index":"","fulltext":""},{"type":"editorAssigned","content":"","date":"2026-08-09T21:30:20+00:00","index":"","fulltext":""}],"rejectedJournal":[],"revision":"","amendment":"","status":"under-review","subjectAreas":[{"id":74364754,"name":"Biological sciences/Cancer"},{"id":74364755,"name":"Biological sciences/Cell biology"},{"id":74364756,"name":"Health sciences/Diseases"},{"id":74364757,"name":"Health sciences/Oncology"}],"tags":[],"updatedAt":"2026-08-25T00:55:11+00:00","versionOfRecord":[],"versionCreatedAt":"2026-08-25 00:55:10","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-10497180","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-10497180","identity":"rs-10497180","version":["v1"]},"buildId":"-D5TCW68w8eVRRLyjaTIo","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: preprint-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (40)

Source provenance

europepmc
last seen: 2026-10-14T06:22:33.750792+00:00
openalex
last seen: 2026-10-14T06:01:35.214979+00:00
License: CC0 · commercial use OK